Leukemia (chronic lymphatic)

Fludarabine in the treatment of chronic lymphocytic leukemia: a review.
[19436622] Ther Clin Risk Manag 5(1): 187-207 (2009)

Fludarabine phosphate for the first-line treatment of chronic lymphocytic leukaemia.
[19567212] Health Technol Assess 13 Suppl 1(-): 35-40 (2009)

Targeted therapy for chronic lymphocytic leukemia.
[19343298] Target Oncol 4(1): 11-21 (2009)

Chronic lymphocytic leukaemia: a short overview.
[18790975] Ann Oncol 19 Suppl 7(-): vii320-5 (2008)

Chronic lymphocytic leukemia: ESMO clinical recommendations for diagnosis, treatment and follow-up.
[18456771] Ann Oncol 19 Suppl 2(-): ii60-2 (2008)

The biology and treatment of chronic lymphocytic leukemia.
[17018715] Ann Oncol 17 Suppl 10(-): x144-54 (2006)

Biology and treatment of chronic lymphocytic leukemia.
[15958440] Ann Oncol 16 Suppl 2(-): ii113-23 (2005)

CD40 activation: potential for specific immunotherapy in B-CLL.
[15151939] Ann Oncol 15(6): 853-7 (2004)

Chronic lymphocytic leukemia: putting new treatment options into perspective.
[20404796] Cancer Control 17(2 Suppl): 4-15; quiz 16 (2010)

NCCN: New directions in chronic lymphocytic leukemia.
[11760553] Cancer Control 8(6 Suppl 2): 114-7 (2001)

Chronic lymphocytic leukemia: recent advances in diagnosis and treatment.
[16401710] Oncologist 11(1): 21-30 (2006)

Chronic lymphocytic leukemia.
[10551552] Oncologist 4(5): 352-69 (1999)

Narrative review: initial management of newly diagnosed, early-stage chronic lymphocytic leukemia.
[16983131] Ann Intern Med 145(6): 435-47 (2006)

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines.
[18216293] Blood 111(12): 5446-56 (2008)

How I treat refractory CLL.
[16204307] Blood 107(4): 1276-83 (2006)

Perspectives on the use of new diagnostic tools in the treatment of chronic lymphocytic leukemia.
[16223776] Blood 107(3): 859-61 (2006)

Prognosis at diagnosis: integrating molecular biologic insights into clinical practice for patients with CLL.
[14576043] Blood 103(4): 1202-10 (2004)

Management of chronic lymphocytic leukemia: practice guidelines from the Italian Society of Hematology, the Italian Society of Experimental Hematology and the Italian Group for Bone Marrow Transplantation.
[17145603] Haematologica 91(12): 1662-73 (2006)

Chronic lymphocytic leukemia: from palliative therapy to curative intent.
[9718872] Haematologica 83(7): 660-2 (1998)

State-of-the-art treatment of chronic lymphocytic leukemia.
[20008230] Hematology Am Soc Hematol Educ Program -(-): 440-9 (2009)

Comprehensive management of the CLL patient: a holistic approach.
[18024647] Hematology Am Soc Hematol Educ Program -(-): 324-31 (2007)

Chronic lymphocytic leukemia (CLL): first-line treatment.
[16304393] Hematology Am Soc Hematol Educ Program -(-): 285-91 (2005)

Biology and treatment of chronic lymphocytic leukemia.
[14633781] Hematology Am Soc Hematol Educ Program -(-): 153-75 (2003)

Chronic lymphocytic leukemia: case-based session.
[11722982] Hematology Am Soc Hematol Educ Program -(-): 140-56 (2001)

Chronic lymphocytic leukemia: diagnosis and treatment.
[16901035] Mayo Clin Proc 81(8): 1105-29 (2006)

Chronic lymphoid leukemias other than chronic lymphocytic leukemia: diagnosis and treatment.
[16342661] Mayo Clin Proc 80(12): 1660-74 (2005)

Current approach to diagnosis and management of chronic lymphocytic leukemia.
[15008611] Mayo Clin Proc 79(3): 388-98 (2004)

Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
[20555070] Ann Oncol 21 Suppl 5(-): v162-4 (2010)

Chronic lymphocytic leukemia: ESMO minimum clinical recommendations for diagnosis, treatment and follow-up.
[19454423] Ann Oncol 20 Suppl 4(-): 102-4 (2009)

Beyond hairy cell: the activity of cladribine in other hematologic malignancies.
[20634380] Blood 116(16): 2884-96 (2010)

How I treat CLL up front.
[19850738] Blood 115(2): 187-97 (2010)

The proposed diagnostic criteria change for chronic lymphocytic leukemia: unintended consequences?
[19541837] Blood 113(25): 6495-6 (2009)

Lymphocytes, B lymphocytes, and clonal CLL cells: observations on the impact of the new diagnostic criteria in the 2008 Guidelines for Chronic Lymphocytic Leukemia (CLL).
[19541838] Blood 113(25): 6496-7; author reply 6497-8 (2009)

Chronic lymphocytic leukemia: interplay between noncoding RNAs and protein-coding genes.
[19745066] Blood 114(23): 4761-70 (2009)

Inflammation, the microenvironment and chronic lymphocytic leukemia.
[21357715] Haematologica 96(3): 353-5 (2011)

Chronic lymphocytic leukemia and autoimmunity: a systematic review.
[21242190] Haematologica 96(5): 752-61 (2011)

Chronic lymphocytic leukemia: novel prognostic factors and their relevance for risk-adapted therapeutic strategies.
[15749671] Haematologica 90(3): 391-9 (2005)

Immune dysfunction in chronic lymphocytic leukemia T cells and lenalidomide as an immunomodulatory drug.
[19734414] Haematologica 94(9): 1198-202 (2009)

Current and investigational therapies for patients with CLL.
[17124074] Hematology Am Soc Hematol Educ Program -(-): 285-94 (2006)

Signal transduction inhibitor therapy for lymphoma.
[21239804] Hematology Am Soc Hematol Educ Program 2010(-): 265-70 (2010)

Chronic lymphocytic leukemia: prognostic factors and impact on treatment.
[21356166] Discov Med 11(57): 115-23 (2011)

Novel therapeutics approaches to chronic lymphocytic leukemia based on recent biological insights.
[19833065] Discov Med 8(42): 157-64 (2009)

Chronic lymphocytic leukemia: treatment options for patients with refractory disease.
[19536902] Cancer 115(17): 3830-41 (2009)

Rituximab for the treatment of relapsed/refractory chronic lymphocytic leukaemia.
[21047487] Health Technol Assess 14(Suppl. 2): 19-26 (2010)

The clinical effectiveness and cost-effectiveness of rituximab for the first-line treatment of chronic lymphocytic leukaemia: an evidence review of the submission from Roche.
[21047488] Health Technol Assess 14(Suppl. 2): 27-32 (2010)

Dutch guidelines for diagnosis and treatment of chronic lymphocytic leukaemia 2011.
[22058261] Neth J Med 69(10): 422-9 (2011)

Refractory chronic lymphocytic leukemia--new therapeutic strategies.
[21317446] Oncotarget 1(7): 472-82 (2010)

IL-24 induces apoptosis of chronic lymphocytic leukemia B cells engaged into the cell cycle through dephosphorylation of STAT3 and stabilization of p53 expression.
[18941194] J Immunol 181(9): 6051-60 (2008)

Targeting endoplasmic reticulum protein transport: a novel strategy to kill malignant B cells and overcome fludarabine resistance in CLL.
[16144803] Blood 107(1): 222-31 (2006)

Alemtuzumab in chronic lymphocytic leukemia.
[17593982] Curr Oncol 14(3): 96-109 (2007)

Update in the management of chronic lymphocytic leukemia.
[19619273] J Hematol Oncol 2(-): 29 (2009)

Familial chronic lymphocytic leukemia.
[20389242] Curr Opin Hematol 17(4): 350-5 (2010)

Philadelphia chromosome-positive leukemias: from basic mechanisms to molecular therapeutics.
[12755554] Ann Intern Med 138(10): 819-30 (2003)

Murine models of chronic lymphocytic leukaemia: role of microRNA-16 in the New Zealand Black mouse model.
[17941951] Br J Haematol 139(5): 645-57 (2007)

The elusive chronic myeloid leukemia stem cell: does it matter and how do we eliminate it?
[20875553] Semin Hematol 47(4): 362-70 (2010)

Antibody therapy for chronic lymphocytic leukemia.
[18381104] Semin Hematol 45(2): 95-103 (2008)

Chronic lymphocytic leukaemia: a disease of activated monoclonal B cells.
[20620969] Best Pract Res Clin Haematol 23(1): 33-45 (2010)

Autoimmune complications in chronic lymphocytic leukaemia (CLL).
[20620970] Best Pract Res Clin Haematol 23(1): 47-59 (2010)

Adoptive T-cell immunotherapy of chronic lymphocytic leukaemia.
[18790444] Best Pract Res Clin Haematol 21(3): 375-89 (2008)

Inherited predisposition to chronic lymphocytic leukemia.
[19802369] Expert Rev Hematol 1(1): 51-61 (2008)

The emerging role of ofatumumab in the treatment of chronic lymphocytic leukemia.
[21499555] Clin Med Insights Oncol 5(-): 45-53 (2011)

CD5-positive chronic B-cell lymphoproliferative disorders: diagnosis and prognosis of a heterogeneous disease entity.
[20568273] Cytometry B Clin Cytom 78 Suppl 1(-): S35-41 (2010)

Clinical utility of assessing ZAP-70 and CD38 in chronic lymphocytic leukemia.
[16906583] Cytometry B Clin Cytom 70(4): 209-13 (2006)

Clinical implications of ZAP-70 expressionin chronic lymphocytic leukemia.
[16906580] Cytometry B Clin Cytom 70(4): 214-7 (2006)

Flow cytometry for ZAP-70: New colors for chronic lymphocytic leukemia.
[16906579] Cytometry B Clin Cytom 70(4): 201-3 (2006)

The spectrum of use of rituximab in chronic lymphocytic leukemia.
[21289858] Onco Targets Ther 3(-): 227-46 (2010)

Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities.
[21148333] Blood 117(6): 1781-91 (2011)

Novel agents for the treatment of chronic lymphocytic leukemia.
[21326166] Clin Adv Hematol Oncol 8(12): 886-95 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Leukemia (chronic lymphatic).php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Leukemia (chronic lymphatic).php on line 92